EUVIMEDEUVIMED entdecken
Crossref

Orally Delivered Tolerogenic Nanotherapeutic for Targeted Colitis Therapy via ROS Scavenging and Treg/Th17 Modulation

Dong Kwang Min, Xin Wang Mo, Jaeyun Kim iD

ACS Applied Materials & Interfaces · 2025

DOI: 10.1021/acsami.5c13156 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Dong Kwang Min und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Engineering, Sungkyunkwan University (SKKU), Suwon 16419, Republic of Korea. Hauptthemen laut MEDLINE: Colitis, Nanoparticles. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Ministry of Science and ICT, South Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColitisNanoparticlesAnimalsMiceReactive Oxygen SpeciesTh17 CellsT-Lymphocytes, RegulatoryPolymersDextran SulfateTanninsAdministration, OralIndolesMice, Inbred C57BLDisease Models, Animal

Stichwörter der Autor:innen

inflammatory bowel diseasemesoporous polydopamine nanoparticlemetforminprebiotictannic acid

Substanzen

Reactive Oxygen SpeciesPolymersDextran SulfateTanninspolydopamineIndoles

Autor:innen und Institutionen

  • School of Chemical Engineering, Sungkyunkwan University (SKKU), Suwon 16419, Republic of Korea.
  • Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University (SKKU), Suwon 16419, Republic of Korea.
  • Department of MetaBioHealth, Sungkyunkwan University (SKKU), Suwon 16419, Republic of Korea.
  • Biomedical Institute for Convergence at SKKU (BICS), Sungkyunkwan University (SKKU), Suwon 16419, Republic of Korea.
  • Institute of Quantum Biophysics (IQB), Sungkyunkwan University (SKKU), Suwon 16419, Republic of Korea.

ORCID-Profile: Jaeyun Kim

Förderung

  • Ministry of Science and ICT, South Korea

Zitieren

APA

Min, D. K., Mo, X. W., & Kim, J. (2025). Orally Delivered Tolerogenic Nanotherapeutic for Targeted Colitis Therapy via ROS Scavenging and Treg/Th17 Modulation. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c13156

Vancouver

Min DK, Mo XW, Kim J. Orally Delivered Tolerogenic Nanotherapeutic for Targeted Colitis Therapy via ROS Scavenging and Treg/Th17 Modulation. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.5c13156

BibTeX
@article{Min2025,
  author = {Min, Dong Kwang and Mo, Xin Wang and Kim, Jaeyun},
  title = {Orally Delivered Tolerogenic Nanotherapeutic for Targeted Colitis Therapy via ROS Scavenging and Treg/Th17 Modulation},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  doi = {10.1021/acsami.5c13156}
}
Kostenlos starten →